We are live on ! Find out more
PCM

Perkins Capital Management Portfolio holdings

AUM $133M
1-Year Est. Return 127.86%
This Fund
S&P 500
This Quarter Est. Return
+53.73%
1 Year Est. Return
+127.86%
3 Year Est. Return
+303.11%
5 Year Est. Return
+333.48%
10 Year Est. Return
–
AUM
$133M
AUM Growth
+$26.3M
Cap. Flow
-$8.45M
Cap. Flow %
-6.35%
Top 10 Hldgs %
52.22%
Holding
90
New
4
Increased
8
Reduced
47
Closed
11

Top Buys

Rank Stock Value
1
CREX icon
Creative Realities
CREX
+$1.13M
2
VIDA
VIDA Global Inc
VIDA
+$971K
3
QTI
QT Imaging Holdings
QTI
+$556K
4
CXDO icon
Crexendo
CXDO
+$141K
5
PERI icon
Perion Network
PERI
+$79.6K

Top Sells

Rank Stock Value
1
INGN icon
Inogen
INGN
+$1.23M
2
QUIK icon
QuickLogic
QUIK
+$856K
3
AXGN icon
Axogen
AXGN
+$847K
4
NTRA icon
Natera
NTRA
+$788K
5
CPSH icon
CPS Technologies
CPSH
+$750K

Sector Composition

Rank Sector Weight
1 Healthcare 55.3%
2 Technology 28.21%
3 Communication Services 9.68%
4 Industrials 4.29%
5 Consumer Staples 1.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ABBV icon
26
AbbVie
ABBV
$451B
$1.34M 1%
5,307
-35
-0.7% -$7.53K
CREX icon
27
Creative Realities
CREX
$38.6M
$1.24M 0.93%
+300,050
New +$1.13M
LUCD icon
28
Lucid Diagnostics
LUCD
$189M
$1.2M 0.91%
1,125,000
-1,000
-0.1% -$1.08K
CDXS icon
29
Codexis
CDXS
$174M
$1.19M 0.89%
526,100
-1,400
-0.3% -$3.48K
ZETA icon
30
Zeta Global
ZETA
$7.67B
$1.1M 0.83%
55,900
– –
TLSI icon
31
TriSalus Life Sciences
TLSI
$297M
$1.07M 0.8%
235,101
+5,000
+2% +$19.9K
TELA icon
32
TELA Bio
TELA
$31.4M
$1.03M 0.78%
1,375,042
-43,286
-3% -$35.4K
BDSX icon
33
Biodesix
BDSX
$283M
$1.01M 0.76%
44,618
-165
-0.4% -$2.45K
SPAI
34
Safe Pro Group Inc
SPAI
$94.3M
$998K 0.75%
230,500
-750
-0.3% -$3.42K
MRK icon
35
Merck
MRK
$366B
$964K 0.72%
7,500
-250
-3% -$29.3K
GILD icon
36
Gilead Sciences
GILD
$181B
$912K 0.69%
7,216
– –
VTRS icon
37
Viatris
VTRS
$18.8B
$855K 0.64%
53,837
-1,058
-2% -$16.4K
PFE icon
38
Pfizer
PFE
$159B
$813K 0.61%
33,759
-2,150
-6% -$56.2K
BKSY icon
39
BlackSky Technology
BKSY
$970M
$803K 0.6%
28,750
– –
AAPL icon
40
Apple
AAPL
$4.67T
$767K 0.58%
2,650
– –
PROF
41
Profound Medical
PROF
$250M
$760K 0.57%
114,280
– –
USB icon
42
US Bancorp
USB
$97.3B
$746K 0.56%
12,350
-200
-2% -$11.2K
NMTC icon
43
NeuroOne Medical Technologies
NMTC
$16.1M
$744K 0.56%
244,656
-844
-0.3% -$3.45K
VIDA
44
VIDA Global Inc
VIDA
$39.4M
$700K 0.53%
+250,000
New +$971K
TGT icon
45
Target
TGT
$74.1B
$620K 0.47%
4,750
-150
-3% -$19.1K
OWLT icon
46
Owlet
OWLT
$146M
$611K 0.46%
106,495
+400
+0.4% +$2.11K
ELWT
47
Elauwit Connection Inc
ELWT
$47.1M
$598K 0.45%
55,500
– –
MDXH icon
48
MDxHealth
MDXH
$68.8M
$580K 0.44%
1,411,891
-64,550
-4% -$86.7K
STX icon
49
Seagate
STX
$188B
$507K 0.38%
525
-25
-5% -$19.1K
ATRC icon
50
AtriCure
ATRC
$2.47B
$490K 0.37%
17,500
-8,600
-33% -$242K
1
2
3 4

Similar funds

AA
Alpha Advisors Richmond, Virginia $133M AUM 20.23% 1-Year Est. Return
WA
Winter & Associates St. Paul, Minnesota $133M AUM
AC
Aldebaran Capital Carmel, Indiana $133M AUM 42.18% 1-Year Est. Return
BCVI
Bain Capital Venture Investors Boston, Massachusetts $133M AUM 50.19% 1-Year Est. Return
SWM
Sherman Wealth Management Gaithersburg, Maryland $133M AUM
HAP
Harbor Asset Planning Belmont, Massachusetts $133M AUM 24.86% 1-Year Est. Return
RHIG
R.H. Investment Group Scottsdale, Arizona $133M AUM 23.61% 1-Year Est. Return
CWM
Capstone Wealth Management Billings, Montana $133M AUM

Perkins Capital Management's Q2 2026 Portfolio in Review

As of Q2 2026, Perkins Capital Management held 90 positions worth $133M, up 25% from $107M the previous quarter. Its ten largest holdings account for 52% of the portfolio.

Perkins Capital Management withdrew a net $8.45M in Q2 2026, closing 11 positions and reducing 47 holdings. Its most notable exit was Inogen, an estimated $1.23M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 55% of assets, down from 63% a quarter earlier, followed by Technology and Communication Services.

Against the trend, Perkins Capital Management opened a new position in Creative Realities worth $1.24M.

  • Perkins Capital Management's largest Q2 2026 buy was Creative Realities: 300,050 shares worth $1.24M.
  • Perkins Capital Management added most to Crexendo in Q2 2026, an estimated $141K increase.
  • Perkins Capital Management's biggest Q2 2026 reduction was QuickLogic, cutting an estimated $856K.
  • Perkins Capital Management fully exited Inogen in Q2 2026, selling an estimated $1.23M.
  • Perkins Capital Management's ten largest holdings make up 52% of its $133M portfolio in Q2 2026.
  • Perkins Capital Management opened 4 new positions and closed 11 in Q2 2026.
  • Perkins Capital Management's portfolio value rose 25% quarter-over-quarter to $133M.

Based on Perkins Capital Management's 13F filing for Q2 2026, filed 24 Jul 2026.